The BRACE Award competition aims to identify and invest in innovative oncology startups that can impact cancers prevalent in underserved populations. It is part of AIM-HI’s annual oncology venture competitions intended to accelerate life-saving innovations through seed support, coaching, and network access. Winners can receive honorariums and may be considered for further investment after due diligence.
Eligibility Criteria:
- Oncology startup aligned with addressing cancers prevalent in underserved populations.
- Must fit AIM-HI’s oncology scientist-entrepreneur/venture competition scope.
Funding Details:
- AIM-HI provides seed funding, coaching, and continuous access to its global network.
- Top winners: honorariums, certificates, and potential further investment consideration.
Deadline:
- Applications accepted until: March 15, 2026.
Where to go for further information: